Skip to main content

MoneyWorks4Me

Cadila Healthcare informs about press release

23 Apr 2021 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated April 23, 2021 titled ‘Zydus Cadila receives final approval from USFDA for Propafenone Hydrochloride Extended-Release Capsules’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..